"Our confidence is high that we can replicate the success and similarly established category leadership in key international markets such as Canada, the U.K., Australia and other European countries
Originally developed to manage type 2 diabetes, these medications mimic the GLP-1 hormone, which plays a key role in regulating appetite, slowing gastric emptying, and enhancing feelings of fullness
[18] Other research suggests that several pharmaceutical companies, including AstraZeneca, Zealand Pharma, Roche, and Amgen, are expected to enter the GLP-1 market, with multiple drug launches planned between 2027 and 2032
Step 3: Factor Analysis: After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the GLP-1 Analogues market
Cardiovascular diseases, though crucial, constitute a smaller share compared to the other two indications, reflecting a more specialized approach in GLP-1 drug applications for these diseases
Nausea: A very common side effect of GLP-1s